Perbedaan Elang Mahkota Teknologi Tbk. dan Organon Pharma Indonesia Tbk.: Elang Mahkota Teknologi Tbk. diperdagangkan di Rp500 (kapitalisasi pasar 30,71 T, volume 24 jam 52,1 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Elang Mahkota Teknologi Tbk. jauh lebih besar — sekitar 294,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| EMTK | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 30,71 T | 104,4 M |
Volume | 52,1 jt | — |
Lot | 520,97 rb | — |
Perputaran | 25,95 M | — |
Harga Rata-rata | 498,1 | — |
Nilai Transaksi | 25,95 M | — |
Harga Ekuilibrium Indikatif | 500 | — |
Volume Ekuilibrium Indikatif | 39,77 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Elang Mahkota Teknologi Tbk (the Company) was established based on Notarial Deed No.7 dated August 3, 1983 of Soetomo Ramelan, S.H.. The Company is engaged in services, specifically in providing technology, media, and telecommunication services, trading, construction, and industry. Company started its commercial operation in 1984.
Selengkapnya di halaman EMTK →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →